The molecular basis of penicillin resistance in *S. pneumoniae* is:

Alteration of penicillin-binding protein

Production of beta-lactamase enzyme

All of the following are true about methicillin resistance in MRSA, except:

Resistance is primarily mediated/transmitted by plasmids

Resistance is produced as a result of altered PBPs

Resistance may be missed at incubation temperature of 37°C during susceptibility testing

Resistance is associated with increased minimum inhibitory concentrations (MICs) for beta-lactam antibiotics

All are false about tigecycline, except:-

It is a broad spectrum antimicrobial

90% pseudomonas strains are sensitive

Dose reduction is required in renal failure

Why does Mycoplasma genitalium show a higher rate of antimicrobial resistance compared to other STI pathogens?

Due to rapid mutation in the 23S rRNA gene

Due to plasmid exchange with other bacteria

Due to absence of cell wall making beta-lactams ineffective

Due to biofilm formation protecting from antibiotics

A 31-year-old man presents with dysuria and urethral discharge. Gram stain shows intracellular gram-negative diplococci. Local resistance patterns show 28% quinolone resistance. Which of the following most appropriately guides empiric therapy selection?

Local antimicrobial susceptibility patterns

Organism identification confirmation

Antimicrobial Resistance for FMGE: High-Yield Pharmacology Lessons

AMR Fundamentals - Resistance Rising

Antimicrobial Resistance (AMR): Microbe's ability to survive/grow despite antimicrobial agent exposure, making infections harder to treat.
Types of Resistance:
- Intrinsic (Natural): Innate characteristic of a microbe (e.g., Gram-negatives resistant to Vancomycin due to outer membrane).
- Acquired: Microbe develops resistance through genetic change (mutation) or horizontal gene transfer (HGT - conjugation, transduction, transformation).
Impact: ↑ Treatment failure, prolonged illness, ↑ healthcare costs, ↑ mortality.

AMR: Global Health Threat, Risks, and Drivers

⭐ ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species) are critical due to high resistance rates and causing nosocomial infections. They effectively "escape" common antibiotics.

Resistance Mechanisms - Bacterial Armoury

Bacteria employ an arsenal of mechanisms to evade antimicrobial action, leading to resistance.

Bacterial Antibiotic Resistance Mechanisms

Mechanism Type	Drugs Affected	Examples (Gene/Species)
1. Enzymatic Inactivation	β-lactams, Aminoglycosides, Macrolides, Chloramphenicol	β-lactamases (bla), AAC, CAT (S. aureus, E. coli)
2. Target Site Modification	Penicillins (PBPs), Macrolides (rRNA), FQs (Gyrase), Vancomycin (Peptide)	MRSA (mecA), VRE (vanA), erm genes
3. ↓ Permeability / Porin Loss	β-lactams, Tetracyclines, FQs	P. aeruginosa (OprD loss)
4. Efflux Pumps (MDR)	Tetracyclines, Macrolides, FQs, β-lactams	P. aeruginosa, E. coli (AcrAB-TolC)
5. Target Protection	FQs (DNA gyrase), Tetracyclines (Ribosome)	Qnr proteins, Tet(O), Tet(M)
6. Target Bypass/Overproduction	Sulfonamides (DHPS), Trimethoprim (DHFR)	↑PABA (Sulfa), ↑DHFR (TMP)

Gene Transfer - Superbug Shuffle

Rapid spread of antimicrobial resistance (AMR) genes, mainly by Horizontal Gene Transfer (HGT). 📌 CTT for HGT: Conjugation, Transduction, Transformation.

HGT Mechanisms:
- Conjugation: "Bacterial sex"; plasmid (R-factor) transfer via pilus. Common in Gram (-).
- Transduction: Bacteriophage mediates DNA transfer.
- Transformation: Uptake of naked DNA by competent cells.
Mobile Genetic Elements (MGEs): Vehicles for AMR genes.
- Plasmids: Extrachromosomal DNA; often carry multiple resistance genes (MDR).
- Transposons: "Jumping genes"; move within/between DNA.
- Integrons: Capture & express gene cassettes (arrays of AMR genes).

Horizontal Gene Transfer Mechanisms

⭐ Plasmids often carry multiple resistance genes, conferring multi-drug resistance (MDR) in one transfer, rapidly creating "superbugs".

Key Culprits & Countermeasures - Villains & Vigilance

Key Villains (Resistant Organisms):
- MRSA (Methicillin-Resistant S. aureus): Common in skin/soft tissue infections, pneumonia.
- VRE (Vancomycin-Resistant Enterococci): Cause UTIs, bacteremia, endocarditis.
- ESBLs (Extended-Spectrum β-Lactamase producers): e.g., E. coli, Klebsiella; resist most β-lactams (not carbapenems/cephamycins).
- CREs (Carbapenem-Resistant Enterobacteriaceae): e.g., KPC, NDM-1, OXA-48; "nightmare bacteria", high mortality.
Vigilance (Countermeasures):
- Antimicrobial Stewardship (AMS): Optimize use, prevent resistance development.
- Infection Prevention & Control (IPC): Hand hygiene, isolation, active surveillance.
- New Drug Development & Novel Therapies: e.g., phage therapy, new antibiotics.
- Rapid Diagnostics: Quick identification of pathogens & resistance patterns.

⭐ NDM-1 (New Delhi Metallo-beta-lactamase-1) confers broad β-lactam resistance (incl. carbapenems); plasmid-mediated spread is a major concern in India.

High‑Yield Points - ⚡ Biggest Takeaways

Intrinsic resistance is inherent; acquired resistance via mutation or horizontal gene transfer (e.g., plasmids).

ESBLs resist most penicillins & cephalosporins; treat with carbapenems or beta-lactamase inhibitor combinations.

MRSA (mecA gene, altered PBP2a) treated with vancomycin, linezolid, daptomycin.

VRE (VanA/VanB genes) treated with linezolid, daptomycin.

Carbapenemases (KPC, NDM-1) hydrolyze carbapenems, severely limiting options.

Efflux pumps and target site modification are major mechanisms of multi-drug resistance (MDR).

Continue reading on Oncourse

CONTINUE READING — FREE

or get the app

App Store|Google Play